title: Clinical implications for cannabinoid use in the rheumatic diseases: potential for help or harm?
authors.affiliation: McGill University Health Center and McGill University, Montreal, Quebec, Canada. mary-ann.fitzcharles@muhc.mcgill.ca
authors.forename: Mary-Ann
authors.initials: MA
authors.lastname: Fitzcharles
authors.forename: Jason
authors.initials: J
authors.lastname: McDougall
authors.forename: Peter A
authors.initials: PA
authors.lastname: Ste-Marie
authors.forename: Ivan
authors.initials: I
authors.lastname: Padjen
mesh_terms: D018771:Arthralgia / Q000188:drug therapy / Q000209:etiology; D001842:Bone and Bones / Q000187:drug effects / Q000378:metabolism; D002186:Cannabinoids / Q000009:adverse effects* / Q000494:pharmacology / Q000627:therapeutic use*; D003072:Cognition Disorders / Q000139:chemically induced; D019468:Disease Management; D006801:Humans; D007107:Immune System / Q000187:drug effects; D029424:Pulmonary Disease, Chronic Obstructive / Q000139:chemically induced; D012216:Rheumatic Diseases / Q000150:complications / Q000188:drug therapy*
chemical_list: D002186:Cannabinoids